Global Health Conversations – Détails, épisodes et analyse

Détails du podcast

Informations techniques et générales issues du flux RSS du podcast.

Global Health Conversations

Christiana

Forme & Santé

Société & Culture

Sciences

Fréquence : 1 épisode/18j. Total Éps: 29

Global Health Conversations explores the most important topics in the worlds of public health, medicine, science and development. From infectious diseases to scientific career paths and healthcare policy, Global Health Conversations are nuanced discussions covering topics impacting global public health with informed and researched positions. Guests share their stories, research findings, and solutions to some of the most pressing health challenges facing our world today. Join the conversation. Read more: https://globalhealthwriter.com/2023/03/13/global-health-conversations-podcast-launches-april-2023/

Lire plusRéduire

Site

RSS

Apple

Données mises à jour le 04/07/2026

Classements récents

Dernières positions dans les classements Apple Podcasts et Spotify.

Apple Podcasts

🇬🇧 Grande Bretagne - Medicine
29/11/2024
#95

Spotify

Aucun classement récent disponible

Liens partagés entre épisodes et podcasts

Liens présents dans les descriptions d'épisodes et autres podcasts les utilisant également.

https://globalhealthwriter.com/2017/12/13/w/
3 partages
https://www.un.org/en/observances/humanitarian-day
2 partages
https://globalhealthwriter.com/2023/03/13/global-health-conversations-podcast-launches-april-2023/
2 partages

https://globalhealthconversations.substack.com/?utm_source=substack&amp
21 partages
https://globalhealthconversations.substack.com/
8 partages
https://globalhealthconversations.substack.com
4 partages

https://www.buzzsprout.com/2153401/support
29 partages
https://www.buzzsprout.com/2153401/12987274
1 partage

Qualité et score du flux RSS

Évaluation technique de la qualité et de la structure du flux RSS.

Qualité du flux RSS

Correct

Score global : 78%

Historique des publications

Répartition mensuelle des publications d'épisodes au fil des années.

Year

Derniers épisodes publiés

Liste des épisodes récents, avec titres, durées et descriptions.

#25: Shaping Public Health & Epidemiology: The Story of John Snow and the Broad Street Pump

Saison 2 · Épisode 25

dimanche 27 octobre 2024 • Durée 14:42

A Storytime:

The story of Cholera in London in the 1800s and how John Snow’s famous experiments revolutionised epidemiology and public health as we know it in modern, western history has always been a favourite for me.

I was reminded of this story strolling through Soho past the John Snow pub recently and past the famous Broad Street pump. This podcast episode is a public health bedtime story; one of science and pioneering innovation. It’s a story we know, but one that ignited something in me, and I like to listen to things.

I hope you enjoy the story. :)

Read the global health conversations newsletter here - where the magic happens: https://globalhealthconversations.substack.com/

Support the show

Lire plusRéduire

#24: What is the Pandemic Accord, really?

Saison 2 · Épisode 24

dimanche 29 septembre 2024 • Durée 27:42

A walkthrough. The Pandemic Accord is a proposed global agreement aimed at strengthening pandemic prevention, preparedness, and response. Emerging in the aftermath of COVID-19, the accord aims to address gaps in international coordination, surveillance, and equitable access to medical countermeasures, globally.

This episode takes a high level overview of the Pandemic Accord, it’s purpose and a walkthrough of some of its most pertinent Articles

GHC Newsletter: PANDEMIC ACCORD - Negotiations stall. Failure to reach agreement (focus on PABS) - May 2024

GHC Newsletter: Pandemic Agreement Round-up as INB 11 Concludes - September 2024

Current draft: Pandemic Accord

Timestamps:

Intro: 00:00
Background: 01:15
How it works & the role of WHO: 04:51
Articles 1 - 3: 07:50
Articles 4 & 5 - Prevention & One Health: 08:34
Articles 6 & 7: 11:05
Article 9 - Research & Development: 12:17
Article 10 - Local Manufacturing: 14:28
Article 11 - Tech Transfer & 'know-how': 14:50
Article 12 - Pathogen Access & Benefit Sharing - PABS: 17:36
Articles 13 & 13bis - Supply Chain & Logistics & Procurement & Distribution : 21:00
Alignment with other agreements: 23:18
Article 14 - Regulation & Strengthening: 24:14
End: 24:54

Support the show

Lire plusRéduire

#23: Mpox Update 18/08/2024

Saison 2 · Épisode 23

dimanche 18 août 2024 • Durée 19:37

This fortnight's Newsletter

We need to talk about Mpox - July 21st 2024 Newsletter

Timstamps:

Overview: 00:00
What happened? 03:47
What does it mean? 05:55
What’s next? 11:09

_______________

tl;dr

On August 14, 2024, WHO Director-General Dr. Tedros Adhanom Ghebreyesus declared the ongoing Mpox outbreak a Public Health Emergency of International Concern (PHEIC), the second such declaration in two years. The Africa CDC had also declared Mpox a Public Health Emergency of Continental Security a day earlier. The current outbreak, driven by the more severe Mpox clade Ib, first identified in South Kivu, DRC, has rapidly spread across Central, East, and Southern Africa, reaching countries like Burundi, Kenya, Rwanda, Uganda, and South Africa, with the first European case detected in Sweden.

WHO’s ACT-A and FIND convened a high-level meeting on August 15 to coordinate global efforts to address the outbreak. Key priorities include enhancing surveillance, developing a strategic research agenda, and coordinating global health responses. The WHO Global Preparedness Monitoring Board emphasized the importance of robust systems and medical countermeasures in the response, drawing on lessons from previous pandemics.

Mpox, previously known as monkeypox, is a zoonotic viral disease characterized by fever, rash, pustules, and swollen lymph nodes. The current clade Ib is more virulent and transmissible, though the exact case fatality rate remains uncertain. The 2022 Mpox PHEIC was declared after a global outbreak affecting over 95,000 people in 115 countries, largely through human-to-human transmission.

The PHEIC designation triggers a coordinated global response, including resource mobilization, increased surveillance, and public health measures. The response's success will depend on equitable distribution of medical resources and enhanced surveillance, particularly in underserved regions. WHO and Africa CDC emphasize the need for clear coordination, strategic implementation, and effective communication to manage the outbreak, with a focus on equity and access to diagnostics, vaccines, and therapeutics.____Other links: GPMB resources:

#22: Project 2025 Impact on Healthcare, Women's Health and Regulation

Saison 2 · Épisode 22

dimanche 21 juillet 2024 • Durée 34:31

Subscribe here to the Global Health Conversations Newsletter

Read the full Project 2025 document here: Mandate for Leadership the Conservative Promise

In this fortnight's episode, we explore Project 2025's proposed policies, which could dramatically impact health, women’s health and safety. The plan includes lifetime caps on Medicaid, reducing coverage for millions, and increased out-of-pocket costs for Medicare recipients. It threatens reproductive rights and seeks to curtail the CDC's public health role, potentially weakening responses to health crises. Basically, an anti-epidemic preparedness vision and plan. The changes could result in higher healthcare costs and reduced access to essential services for women and vulnerable populations

Timestamps:

00:00 - Intro

02:00 - Preamble

02:56 - Project 2025 High Level Overview

08:55 - Point 1: Changes to Medicaid, Medicare & Lower income patients

14:20 - Point 2: Impact on Public Health & the new role of the CDC

17:06 - Point 3: Food and Drug regulation proposed changes

22:05 - Point 4: Any comments on Safety, Guns and Ammunition?

24:09 - Point 5: Restrictions around Women’s health, access to birth control & more

Support the show

Lire plusRéduire

#21: Philippines: Twelve Minute Health System Summary

Saison 2 · Épisode 21

dimanche 23 juin 2024 • Durée 11:44

In this mini solo episode, we take a high level look at Philippines' health system.

In under twelve minutes, we take an overview of the health system dynamic, payer mechanisms and the fiscal policies the nation has employed to boost health expenditure 6-fold! We delve into the multifaceted nature of the ongoing epidemiological transition from communicable to non-communicable diseases. Additionally, we explore the impact of the 2024 World Health Assembly on climate-resilient health policies, and the critical issues surrounding health financing and infrastructure improvements. We briefly discuss the diabetes-obesity-hypertension nexus, emphasizing the interconnected nature of these conditions and the need for integrated healthcare approaches to manage and mitigate their impact on public health.

Email me: christiana@globalhealthwriter.com :)

Sign up to the biweekly newsletter: https://globalhealthconversations.substack.com/

Support the show

Lire plusRéduire

BONUS: Real Water - Water gone wrong! A Public Health Scandal

Saison 2

dimanche 23 juin 2024 • Durée 23:24

In this BONUS episode, we delve into the true crime-style medical scandal of Real Water. The company’s negligence led to severe health issues, including acute liver dysfunction in consumers like Megan Fisher’s son, Tommy. Real Water’s aggressive marketing of its unproven E2 technology claimed extraordinary health benefits, but the FDA found a potentially toxic compound in the water, that caused acute hepatitis in some consumers. The ensuing lawsuits and investigations revealed a lack of quality control and corporate greed. This episode underscores the need for stringent regulatory oversight and vigilance in scrutinizing health claims to protect consumers from similar dangers.

In this episode, I use some short clips from this CBS news episode: https://www.youtube.com/watch?v=oJ_Dk_EPGfAw :

Sign up to the newsletter here: https://globalhealthconversations.substack.com/

Check out last summer's True Crime bonus episode: The Case of a Clinical Trial Catastrophe - the TGN1412 ‘Elephant Men’ Clinical trial

Support the show

Lire plusRéduire

#20: The Profitability of Skinny - How Semaglutides made Novo Nordisk Europe's most profitable company

Saison 2 · Épisode 20

dimanche 9 juin 2024 • Durée 25:11

In this episode, we explore the economics of thinness and the phenomenal rise of GLP-1 receptor agonists in the weight loss market. Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, has become Europe's most profitable company, surpassing even the luxury giant LVMH. We delve into the social and economic capital associated with thinness, examining how societal attitudes toward body image drive the profitability of weight loss drugs.

We also break down the science behind GLP-1 receptor agonists, including their mechanisms and market dynamics. We'll discuss the first-in-class drugs like Saxenda, and best-in-class competitors such as Trulicity and Mounjaro. Novo Nordisk’s strategic business moves, including their significant investment in R&D and marketing, have cemented their market dominance. Additionally, we highlight the broader implications of these drugs on global health and their potential for continued growth in a competitive landscape.

Resources

Skinny at all costs? Unravelling the weight loss sensation causing supply chain mayhem
: Q1 Pharma Financials Published Across the sector - Guess who's in the lead?
Economist: The economics of thinness
Lancet: Semaglutide versus GLP-1 agonists
Fortune: Wegovy and Ozempic have ignited a gold rush in pharma as well as an upsurge in fake ‘skinny jabs’, leading to surge in hospitalizations ft Bloomberg
Vanity Fair: Why Counterfeit Ozempic Is a Global- Growth Industry
Economist: The battle over the trillion-dollar weight-loss bonanza Novo Nordisk and Eli Lilly are making blockbuster drugs. Can they maintain their lead?

#19: Drug Licensing and the Pandemic Accord

Saison 2 · Épisode 19

dimanche 28 avril 2024 • Durée 39:37

In this week’s episode, we look at Colombia's recent move in issuing its first compulsory license. The country challenged ViiV Healthcare's monopoly on their patented drug, dolutegravir, an HIV therapeutic, in an attempt to open doors for affordable generic versions and thus improve accessibility & affordability.

We explore the nuances of licensing mechanisms - voluntary agreements & compulsory licenses. We discuss their impact on public health and innovation, drawing parallels with past instances. We also delve into the proposed European Union-wide Compulsory Licence and industry perspectives on intellectual property. Hard subject here - and as someone who started out in Pharma I find it hard to put full advocacy behind non-market driven mechanisms. But what does the data say?

1. Sudan - https://www.rescue.org/article/fighting-sudan-what-you-need-know-about-crisis

Sign up to the Global Health Conversations Newsletter! :)

2. Colombia issues compulsory license for https://healthpolicy-watch.news/colombia-issues-compulsory-license-to-get-key-generic-hiv-medicine-dolutegravir/#:~:text=The%20government%20of%20Colombia%20has,the%20patent%20owner%2C%20ViiV%20Healthcare.

3. ViiV HEALTHCARE STATEMENT ON COMPULSORY LICENCE FOR DOLUTEGRAVIR IN COLOMBIA https://viivhealthcare.com/hiv-news-and-media/news/company-statements/viiv-healthcare-statement-on-compulsory-licence-for-dolutegravir-in-colombia/

4. MPP agreement https://medicinespatentpool.org/licence-post/dolutegravir-adult-dtg

#18: Prioritising Oral Health in Public Health (ft. Ema Prohić) - Part 2

Saison 2 · Épisode 18

dimanche 14 avril 2024 • Durée 48:43

This is Part 2 of our 2 Part interview.

Listen here for Part 1:
- Listen here on Spotify
- Listen here on Apple Podcasts
- Listen here on Audible

Today I interview Ema Prohić and we discuss proper teeth brushing, systemic issues in dental care and continue on the theme of the true cost of oral health. Drawing on her experience in different health systems, we discuss the financing of dental procedures, dentist fear and how to avoid the most common oral health pitfalls. We also discuss a public health project that I lead back in 2020 with the Ministry of Health Qatar and PHCC wherein she focussed on integrating oral health into a primary care program. This is Part 1 of a super conversation this season. And you won't want to miss it.

Ema is a doctor of dental medicine from Croatia, currently undertaking her specialization in orthodontics and facial orthopedics in Barcelona, Spain. She started her professional career as a dentist in the UK after completing her MSc in International Health Management at Imperial College Business School and has continued working in the UK in several dental practices as an NHS and private practitioner.

Join The Conversation - Sign up to the Global Health conversations newsletter: Check out the newsletter

Contact me: christiana@globalhealthwriter.com

Support the show

Lire plusRéduire

#17: Prioritising Oral Health in Public Health (ft. Ema Prohić) - Part 1

Saison 2 · Épisode 17

dimanche 31 mars 2024 • Durée 59:28

On this episode I interview Ema Prohić and we discuss the true cost of oral health. Drawing on her experience in different health systems, we discuss the financing of dental procedures, dentist fear and how to avoid the most common oral health pitfalls. We also discuss a public health project that I lead back in 2020 with the Ministry of Health Qatar and PHCC wherein she focussed on integrating oral health into a primary care program. This is Part 1 of a super conversation this season. And you won't want to miss it.

Ema is a doctor of dental medicine from Croatia, currently undertaking her specialization in orthodontics and facial orthopedics in Barcelona, Spain. She started her professional career as a dentist in the UK after completing her MSc in International Health Management at Imperial College Business School and has continued working in the UK in several dental practices as an NHS and private practitioner.

Resources;

1. Fluoride and caries prevention: a scoping review of public health policies2. NHS dental recovery plan: is this the correct use of limited funding?

Support the show

Lire plusRéduire

Podcasts Similaires Basées sur le Contenu

Découvrez des podcasts liées à Global Health Conversations. Explorez des podcasts avec des thèmes, sujets, et formats similaires. Ces similarités sont calculées grâce à des données tangibles, pas d'extrapolations !

À propos Méthodologie Contact Me soutenir Politique de confidentialité Mentions légales

Global Health Conversations – Détails, épisodes et analyse

Détails du podcast

Classements récents

Apple Podcasts

Spotify

Liens partagés entre épisodes et podcasts

Other53

Substack14

Buzzsprout2

Qualité et score du flux RSS

Historique des publications

Derniers épisodes publiés

Podcasts et contenus similaires

Podcasts Similaires Basées sur le Contenu

Apple Podcasts

Spotify

Podcasts Similaires Basées sur le Contenu

Other53

Substack14

Buzzsprout2